Perceptive Advisors LLC Spring Works Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$2.28 Billion
Q2 2025

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $30.8 Million - $41.1 Million	-960,699 Reduced 58.12%	692,263 $22.2 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $22 Million - $29 Million	-609,500 Reduced 26.94%	1,652,962 $62.3 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $11.1 Million - $16 Million	305,216 Added 15.59%	2,262,462 $111 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $8.27 Million - $16.3 Million	436,830 Added 28.73%	1,957,246 $71.4 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $393,386 - $533,930	-17,015 Reduced 1.11%	1,520,416 $35.2 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $12.5 Million - $17.7 Million	-541,921 Reduced 26.06%	1,537,431 $40.3 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $13.4 Million - $18.3 Million	-538,339 Reduced 20.57%	2,079,352 $53.5 Million
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $18.5 Million - $24.5 Million	-852,872 Reduced 24.57%	2,617,691 $68.1 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $9.56 Million - $15.7 Million	-396,883 Reduced 10.26%	3,470,563 $99 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $12.1 Million - $39.7 Million	-660,547 Reduced 14.59%	3,867,446 $95.2 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $15.8 Million - $21.1 Million	-321,919 Reduced 6.64%	4,527,993 $256 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $43.8 Million - $62.9 Million	672,191 Added 16.09%	4,849,912 $357 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $33.7 Million - $54.3 Million	696,573 Added 20.01%	4,177,721 $303 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $1.2 Million - $1.73 Million	-33,210 Reduced 0.94%	3,481,148 $166 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $689,400 - $1.46 Million	30,000 Added 0.86%	3,514,358 $148 Million
Q1 2020 May 15, 2020	BUY	$20.44 - $41.21 $3 Million - $6.05 Million	146,836 Added 4.4%	3,484,358 $94.1 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $2.13 Million - $4.74 Million	120,000 Added 3.73%	3,337,522 $1.29 Billion
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $60.5 Million - $89.5 Million	3,217,522 New	3,217,522 $69.8 Million

Others Institutions Holding SWTX

# of Institutions

271

Shares Held

72M

Call Options Held

11.8M

Put Options Held

1.27M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account